BLINCYTO
Dr Reddy's Laboratories inks pact with Amgen to commercialise three drugs in IndiaUnder the terms, DRL will commercialise Xgeva (denosumab), Vectibix (panitumumab) and Prolia (denosumab) in India, a company statement said...
Dr Reddy's Lab shares up almost 2% on boursesShares of Dr Reddy's Laboratories rose almost 2% after the company said it has inked a pact with US-based biotechnology firm Amgen to marke...
Dr Reddy's to market three Amgen drugs in IndiaDr Reddy's Laboratories today said it has inked a pact with US-based biotechnology firm Amgen to market its three drugs.
- Load More